King discontinues Tilade Inhaler
King Pharmaceuticals has decided to discontinue the manufacturing of Tilade Inhaler (nedocromil sodium inhalation aerosol). The decision is based upon many factors, including the company's inability to identify a qualified manufacturer for a chlorofluorocarbon propellant inhaler. Tilade Inhaler is indicated for maintenance therapy of mild-to-moderate asthma in adult and pediatric patients ≥6 years of age.
For more information call (800) 776-3637 or visit www.fda.gov/cder/drug/shortages/Tilade_DHCPApril2008.pdf.